GE HealthCare is blending precision medicine with green innovation—and doing it at scale. With solutions like the Et Control software slashing agent use and emissions, and AI-powered Carestation systems redefining accuracy and ease, the company is tackling both surgical safety and climate impact in one go. Add to that its $1B partnership with Sutter Health and a smart acquisition strategy in ultrasound AI, and you’ve got a healthcare powerhouse transforming perioperative workflows and elevating patient care. GE isn’t just keeping up—it’s orchestrating the next leap forward in anesthesia technology. Anesthesia technology continues to evolve, playing a critical role in enhancing patient safety, optimizing surgical workflows, and improving clinical outcomes. GE HealthCare remains at the forefront of these advancements, developing innovative solutions that address the growing complexities of modern anesthesia delivery. From compact anesthesia machines like the Carestation 600 Series V2 to cutting-edge End-tidal Control software integrated within the Aisys™ CS2 Anesthesia Delivery System, GE HealthCare’s commitment to precision, efficiency, and sustainability is evident. With a focus on automation, real-time monitoring, and reduced environmental impact, these technologies are designed to streamline perioperative care while minimizing clinician workload.
Latest Innovations - Products
Carestation 600 Series V2
GE HealthCare Korea introduced the Carestation 600 series V2 (January, 2025), a compact anesthesia machine designed for efficient use in narrow operating rooms. This system automatically calculates a patient's "predicted body weight" based on height, allowing for personalized anesthesia delivery. It also provides real-time driving pressure calculations to ensure proper ventilation and prevent excessive pressure. The ergonomic design aims to enhance patient safety and improve workflow efficiency.
Aisys CS² Anesthesia Delivery System with Et Control
The Aisys™ CS2 Anesthesia Delivery System with Et Control is a digitally advanced solution designed to enhance operational efficiency, patient safety, and environmental sustainability. It integrates End-Tidal (Et) Control software, automating gas and agent delivery for consistent anesthesia levels, reducing manual input, and improving safety. Features like rapid-response ventilation help minimize the risk of postoperative pulmonary complications (PPCs), ensuring individualized therapy. The system also enhances operational efficiency by providing real-time data and decision-support tools, optimizing OR workflow and clinician response.
In terms of cost and environmental impact, the Et Control software reduces anesthetic agent consumption by over 25%, lowering costs and greenhouse gas emissions by 40%. The system’s smart connectivity enables integration with hospital networks for live monitoring, data-driven insights, and cloud-based analysis, improving protocol adherence. Additionally, automated alerts, overdose prevention, and precise gas flow controls contribute to patient safety and clinician ease. The system also supports eco-friendly anesthesia practices, reducing agent waste and promoting greener healthcare solutions.
With a modular and upgradeable design, the Aisys CS2 ensures longevity in an evolving healthcare landscape, making it a future-ready anesthesia platform.
The Carestation™ 750 Anesthesia Delivery System
The Carestation™ 750 Anesthesia Delivery System is a modern, intuitive anesthesia workstation designed to enhance precision, efficiency, and patient safety in perioperative care. Built on GE HealthCare’s clinically proven platform, it offers customizable case profiles for personalized anesthesia delivery based on patient characteristics and procedure type.
Key features include ecoFLOW software, which supports low-flow anesthesia to reduce anesthetic agent waste, costs, and environmental impact. The system’s lung protective ventilation software provides automated lung recruitment maneuvers with real-time compliance monitoring to help reduce postoperative complications. The Adequacy of Anesthesia (AoA) concept assists clinicians in optimizing drug use and patient monitoring.
The user-friendly interface streamlines workflow with direct access to key functions, intelligent lighting, and automated system checks that complete in 3.5 minutes. Its ergonomic design includes a flexible, full-function arm for better positioning, simplified cable management, and compact structure to improve operating room (OR) efficiency.
The Carestation 750 integrates with CARESCAPE patient monitors, offering real-time data analysis and decision-support tools to improve patient outcomes. Additionally, its modular design allows for easy serviceability, reducing downtime and maintenance costs. With advanced technology and seamless connectivity, the system provides a future-ready solution for individualized anesthesia care.
The Tec™ 8 Vaporizers
The Tec™ 8 Vaporizers from GE HealthCare are designed for precise delivery of isoflurane and sevoflurane anesthetic agents. Available in two models—the Tec 820, compatible with both agents, and the Tec 850, dedicated to sevoflurane—they ensure consistent agent output across various clinical flow rates. Features include an ergonomic, easy-to-turn dial suitable for left- or right-hand operation, a wide liquid level indicator for clear visibility, and flexible filling options with a non-spill design to maintain output consistency. The Tec 850 model requires inspection only once every five years, reducing maintenance costs, and integrates seamlessly with GE HealthCare anesthesia machines equipped with the Selectatec™ manifold.
Technological Advancement:
GE HealthCare invests $51M to acquire ultrasound AI for OB/GYN applications.
GE HealthCare will acquire AI assets from Intelligent Ultrasound Group for $51 million in cash, expanding its real-time clinical support capabilities. Intelligent Ultrasound’s ScanNav software, already integrated into GE’s Voluson scanners, enhances OB/GYN exams with AI-driven image recognition. GE plans to apply the technology across its ultrasound portfolio, including anesthesia procedures. This acquisition complements GE’s previous $150 million purchase of Caption Health, which developed AI-powered imaging guidance. Intelligent Ultrasound will retain its simulation and education business focused on echocardiography, pediatrics, and guided procedures.
Growth of Minimally Invasive Surgery:
The global minimally invasive surgery (MIS) market is projected to grow from $79.3 billion in 2024 to $173.9 billion by 2029, at a CAGR of 17.0%. This growth is driven by the increasing adoption of MIS over traditional open surgeries due to benefits such as reduced blood loss, fewer postoperative complications, and shorter recovery times. However, the high costs associated with robotic systems present challenges to market expansion.
GE HealthCare is among the prominent companies in the MIS market, alongside Medtronic, Johnson & Johnson, and Stryker. The company offers advanced imaging and visualization systems that enhance the precision and effectiveness of minimally invasive procedures. By integrating real-time imaging technologies, GE HealthCare's solutions assist surgeons in navigating complex anatomies, thereby improving patient outcomes and reducing recovery times.
In the context of the rapidly growing MIS market, GE HealthCare's continuous innovation and development of imaging technologies position it to meet the increasing demand for minimally invasive procedures. The company's focus on enhancing surgical precision aligns with the market's trajectory towards less invasive treatment options, catering to both patient preferences and clinical efficiency.
Emerging Market Expansion:
GE HealthCare & Sutter Health’s $1B AI-Powered Partnership
GE HealthCare and Sutter Health have formed a seven-year, $1 billion strategic partnership to enhance medical imaging, digital solutions, and AI-powered healthcare. The Care Alliance agreement will standardize GE equipment across Sutter’s 28 acute care facilities and 57,000 employees, reducing costs by $30M-$40M annually through lower expenses, improved maintenance, and operational efficiency.
Key impact on anesthesia and perioperative care:
The collaboration will also expand access to advanced imaging across Sutter’s system, improving diagnostics, workflows, and interoperability between imaging and perioperative services. AI-driven insights will assist radiologists and anaesthesiologists in predicting patient risks, optimizing workflows, and streamlining procedures.
Additionally, Sutter will expand its ambulatory footprint, launching 23 new ambulatory sites and 3 acute care centers, ensuring wider access to integrated anesthesia and surgical services. Workforce development initiatives will train future anesthesiology and imaging professionals, reinforcing healthcare career pathways.
The partnership represents a landmark shift toward data-driven, AI-enabled, and highly coordinated patient care, ensuring faster, safer, and more efficient anesthesia and perioperative management.
Regulatory and Compliance Updates:
Clinical Study Shows Targeted End-tidal Control Anesthesia Delivery Improves Efficiency and Accuracy to Help Optimize Patient Care
Aug 20, 2024.
A multi-site clinical trial published in Anesthesia and Analgesia confirms that GE HealthCare’s FDA-approved End-tidal Control software improves anesthesia delivery efficiency and accuracy compared to manual methods. End-tidal Control is the first FDA-approved software designed to automatically regulate and sustain exhaled oxygen and anesthetic concentrations, achieving the clinician’s target with greater precision than manual control. Results from the MASTER trial show that End-tidal Control significantly outperforms manual control in maintaining target concentrations, achieving faster response times, and reducing anesthetic agent use—leading to lower greenhouse gas emissions and cost savings. The software integrates with the Aisys™ CS2 Anesthesia Delivery System, further optimizing perioperative care.
GE HealthCare’s Commitment to Precision and Planet
As the demand for safer, more efficient, and environmentally sustainable anesthesia solutions rises, GE HealthCare continues to lead with technological innovation. By integrating AI-driven monitoring, low-flow anesthesia techniques, and smart connectivity, GE’s solutions enhance patient care while addressing key challenges such as cost, workflow efficiency, and greenhouse gas emissions. From ultrasound-guided anesthesia applications to AI-powered decision support systems, GE HealthCare is shaping the future of anesthesia with data-driven, patient-centered solutions. These advancements not only improve clinical precision but also set new standards for sustainable
